open access

Ahead of Print
Review paper
Published online: 2024-03-01
Get Citation

Breastfeeding and fatty liver — is there any association?

Weronika Powroslo1, Magdalena Wymyslo-Filipecka2, Agnieszka Drosdzol-Cop1, Brygida Adamek2
·
Pubmed: 38506478
Affiliations
  1. Department and Clinical Department of Gynecology, Obstetrics and Oncological Gynecology, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland
  2. Department of Basic Medical Sciences, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Bytom, Poland, Poland

open access

Ahead of Print
REVIEW PAPERS Gynecology
Published online: 2024-03-01

Abstract

The campaign to promote the natural feeding of infants, at least for the first six months of life, conducted over recent years has deep justification from a medical point of view. Numerous gynecological and pediatric societies around the world recommend breastfeeding as the most appropriate way of feeding infants. It has been proven that the benefits of this type of nutrition go beyond nutritional aspects, proper growth and development. The list of long-term metabolic benefits, which include reducing the incidence of obesity, allergies, infections and diabetes, is constantly growing. It has been shown that the method of feeding infants using various mechanisms may influence the tendency of the liver to accumulate fatty compounds and develop fatty liver disease with its metabolic consequences leading to liver failure, cirrhosis and hepatocellular carcinoma. This is an important discovery due to the growing obesity epidemic in adults and children. Metabolic dysfunction — associated fatty liver disease (MAFLD) has become the most common cause of chronic liver disease, affecting 25% of the global population. The results of studies conducted in recent years have shown the protective effect of breastfeeding on the risk of developing MAFLD later in life in both children and breastfeeding women. New scientific reports provide the basis for qualifying breastfeeding as a modifiable risk factor for MAFLD.

Abstract

The campaign to promote the natural feeding of infants, at least for the first six months of life, conducted over recent years has deep justification from a medical point of view. Numerous gynecological and pediatric societies around the world recommend breastfeeding as the most appropriate way of feeding infants. It has been proven that the benefits of this type of nutrition go beyond nutritional aspects, proper growth and development. The list of long-term metabolic benefits, which include reducing the incidence of obesity, allergies, infections and diabetes, is constantly growing. It has been shown that the method of feeding infants using various mechanisms may influence the tendency of the liver to accumulate fatty compounds and develop fatty liver disease with its metabolic consequences leading to liver failure, cirrhosis and hepatocellular carcinoma. This is an important discovery due to the growing obesity epidemic in adults and children. Metabolic dysfunction — associated fatty liver disease (MAFLD) has become the most common cause of chronic liver disease, affecting 25% of the global population. The results of studies conducted in recent years have shown the protective effect of breastfeeding on the risk of developing MAFLD later in life in both children and breastfeeding women. New scientific reports provide the basis for qualifying breastfeeding as a modifiable risk factor for MAFLD.

Get Citation

Keywords

breastfeeding; metabolic diseases; fatty liver

About this article
Title

Breastfeeding and fatty liver — is there any association?

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Review paper

Published online

2024-03-01

Page views

99

Article views/downloads

58

DOI

10.5603/gpl.97556

Pubmed

38506478

Keywords

breastfeeding
metabolic diseases
fatty liver

Authors

Weronika Powroslo
Magdalena Wymyslo-Filipecka
Agnieszka Drosdzol-Cop
Brygida Adamek

References (16)
  1. WHO. Breastfeeding [Internet]. https://www.who.int/health-topics/breastfeeding#tab=tab_1 (23.09.2023).
  2. Młodawska M, Młodawski J, Pazera G, et al. Breast is the best — what gynecologist should know about breastfeeding. Ginekol Perinatol Prakt. 2019; 4(1): 23–33.
  3. Szajewska H, Horvath A, Rybak A, et al. Breastfeeding. A position paper by the polish society for paediatric gastroenterology, hepatology and nutrition. Stand Med Pediatr. 2016; 13: 9–24.
  4. Truchet S, Honvo-Houéto E. Physiology of milk secretion. Best Pract Res Clin Endocrinol Metab. 2017; 31(4): 367–384.
  5. Meliț LE, Mărginean CO, Săsăran MO. The yin-yang concept of pediatric obesity and gut microbiota. Biomedicines. 2022; 10(3).
  6. Le Garf S, Nègre V, Anty R, et al. Metabolic fatty liver disease in children: a growing public health problem. Biomedicines. 2021; 9(12): 1915.
  7. Ayonrinde OT, Oddy WH, Adams LA, et al. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. J Hepatol. 2017; 67(3): 568–576.
  8. Rajewski P, Rajewski P, Wiciński M, et al. Non-alcoholic fatty liver disease (NAFLD): etiology, diagnosis, treatment in the light of current knowledge. Forum Med Rodzin. 2020; 14(1): 1–10.
  9. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7(9): 851–861.
  10. Abeysekera KWm, Orr JG, Madley-Dowd P, et al. Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study. Lancet Reg Health Eur. 2021; 10: 100206.
  11. Nobili V, Bedogni G, Alisi A, et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child. 2009; 94(10): 801–805.
  12. Rajindrajith S, Pathmeswaran A, Jayasinghe C, et al. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterol. 2017; 17(1): 135.
  13. Mosca A, De Cosmi V, Parazzini F, et al. The role of genetic predisposition, programing during fetal life, family conditions, and post-natal diet in the development of pediatric fatty liver disease. J Pediatr. 2019; 211: 72–77.e4.
  14. Querter I, Pauwels NS, De Bruyne R, et al. Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease: a systematic review. Clin Gastroenterol Hepatol. 2022; 20(4): 740–755.
  15. Ajmera VH, Terrault NA, VanWagner LB, et al. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. J Hepatol. 2019; 70(1): 126–132.
  16. Park Y, Sinn DH, Oh JH, et al. The association between breastfeeding and nonalcoholic fatty liver disease in parous women: a nation-wide cohort study. Hepatology. 2021; 74(6): 2988–2997.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl